{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:55:52Z","timestamp":1774702552118,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA271410"],"award-info":[{"award-number":["U01CA271410"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA15083"],"award-info":[{"award-number":["P30CA15083"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.htct.2025.106233","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:56:55Z","timestamp":1766451415000},"page":"106233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic insights into the antiproliferative effect of the redox-active iron chelator Dp44mT on multiple myeloma cell lines"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8744-1268","authenticated-orcid":false,"given":"Aarti","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latha","family":"Pathangey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinto Sebastian","family":"Chirackal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5791-727X","authenticated-orcid":false,"given":"Kiran K.","family":"Mangalaparthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhilesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5938-3769","authenticated-orcid":false,"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4773-141X","authenticated-orcid":false,"given":"Sundararaman","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.htct.2025.106233_bib0001","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1615\/CritRevOncog.2013007934","article-title":"Iron in multiple myeloma","volume":"18","author":"VanderWall","year":"2013","journal-title":"Crit Rev Oncog"},{"issue":"6","key":"10.1016\/j.htct.2025.106233_bib0002","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.htct.2025.106233_bib0003","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ajh.21350","article-title":"Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells","volume":"84","author":"Noulsri","year":"2009","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.htct.2025.106233_bib0004","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/0008-5472.CAN-08-1437","article-title":"The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells","volume":"69","author":"Rao","year":"2009","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.htct.2025.106233_bib0005","first-page":"5370","article-title":"The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivo","volume":"8","author":"Li","year":"2016","journal-title":"Am J Transl Res"},{"issue":"3","key":"10.1016\/j.htct.2025.106233_bib0006","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s13402-020-00502-y","article-title":"Dp44mT, an iron chelator, suppresses growth and induces apoptosis via RORA-mediated NDRG2-IL6\/JAK2\/STAT3 signaling in glioma","volume":"43","author":"Zhou","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1016\/j.htct.2025.106233_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106806","article-title":"Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer","volume":"193","author":"Shehadeh-Tout","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.htct.2025.106233_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121760","article-title":"Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition","volume":"289","author":"Ismail","year":"2022","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.htct.2025.106233_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17091435","article-title":"The iron chelator, Dp44mT, effectively inhibits human oral squamous cell carcinoma cell growth in vitro and in vivo","volume":"17","author":"Lee","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10.1016\/j.htct.2025.106233_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133302","article-title":"Molecular characterization of esophageal squamous cell carcinoma using quantitative proteomics","volume":"15","author":"Mangalaparthi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"268","key":"10.1016\/j.htct.2025.106233_bib0011","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2003573","article-title":"Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells","volume":"6","author":"Casado","year":"2013","journal-title":"Sci Signal"},{"issue":"1","key":"10.1016\/j.htct.2025.106233_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/nu13010179","article-title":"Iron deficiency reprograms phosphorylation signaling and reduces O-GlcNAc pathways in neuronal cells","volume":"13","author":"Erber","year":"2021","journal-title":"Nutrients"},{"issue":"21","key":"10.1016\/j.htct.2025.106233_bib0013","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1007\/s00018-014-1621-4","article-title":"A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression","volume":"71","author":"Foka","year":"2014","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"10.1016\/j.htct.2025.106233_bib0014","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41416-021-01616-2","article-title":"CSNK2 in cancer: pathophysiology and translational applications","volume":"126","author":"Strum","year":"2022","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.htct.2025.106233_bib0015","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.bbamcr.2016.09.011","article-title":"The anticancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), up-regulates the AMPK-dependent energy homeostasis pathway in cancer cells","volume":"1863","author":"Krishan","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.htct.2025.106233_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165657","article-title":"Regulation of autophagy and apoptosis by Dp44mT-mediated activation of AMPK in pancreatic cancer cells","volume":"1866","author":"Krishan","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"9","key":"10.1016\/j.htct.2025.106233_bib0017","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41419-019-1854-0","article-title":"Ferroportin downregulation promotes cell proliferation by modulating the Nrf2-miR-17-5p axis in multiple myeloma","volume":"10","author":"Kong","year":"2019","journal-title":"Cell Death Dis"},{"issue":"11","key":"10.1016\/j.htct.2025.106233_bib0018","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1158\/0008-5472.CAN-14-3804","article-title":"Decreased ferroportin promotes myeloma cell growth and osteoclast differentiation","volume":"75","author":"Gu","year":"2015","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.htct.2025.106233_bib0019","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/carcin\/bgad015","article-title":"ACSL4: a double-edged sword target in multiple myeloma, promotes cell proliferation and sensitizes cell to ferroptosis","volume":"44","author":"Zhang","year":"2023","journal-title":"Carcinogenesis"},{"issue":"7 Pt A","key":"10.1016\/j.htct.2025.106233_bib0020","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.bbamcr.2016.04.017","article-title":"Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT)","volume":"1863","author":"Gutierrez","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.htct.2025.106233_bib0021","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.chembiol.2022.08.002","article-title":"Ferroptosis execution: is it all about ACSL4?","volume":"29","author":"Lee","year":"2022","journal-title":"Cell Chem Biol"},{"issue":"1","key":"10.1016\/j.htct.2025.106233_bib0022","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12964-023-01170-9","article-title":"The emerging roles of MAPK-AMPK in ferroptosis regulatory network","volume":"21","author":"Wang","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.htct.2025.106233_bib0023","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2021.09.008","article-title":"Endoplasmic reticulum stress-mediated autophagy activation is involved in cadmium-induced ferroptosis of renal tubular epithelial cells","volume":"175","author":"Zhao","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.htct.2025.106233_bib0024","doi-asserted-by":"crossref","unstructured":"Wang Z., Wang N., Liu P., Xie X. AMPK and cancer. Exp Suppl. 2016;107:203\u201326.","DOI":"10.1007\/978-3-319-43589-3_9"},{"issue":"8","key":"10.1016\/j.htct.2025.106233_bib0025","doi-asserted-by":"crossref","first-page":"17193","DOI":"10.3390\/ijms160817193","article-title":"Protein folding and mechanisms of proteostasis","volume":"16","author":"Diaz-Villanueva","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.htct.2025.106233_bib0026","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4103\/1673-5374.380870","article-title":"Ferroptosis and endoplasmic reticulum stress in ischemic stroke","volume":"19","author":"Li","year":"2024","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/j.htct.2025.106233_bib0027","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1158\/1535-7163.39.3.1","article-title":"Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid","volume":"3","author":"Ikeda","year":"2004","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"10.1016\/j.htct.2025.106233_bib0028","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1182\/blood-2016-09-738872","article-title":"Multiple myeloma cells' capacity to decompose H(2)O(2) determines lenalidomide sensitivity","volume":"129","author":"Sebastian","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.htct.2025.106233_bib0029","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jinorgbio.2010.07.012","article-title":"The iron complex of Dp44mT is redox-active and induces hydroxyl radical formation: an EPR study","volume":"104","author":"Jansson","year":"2010","journal-title":"J Inorg Biochem"},{"issue":"17","key":"10.1016\/j.htct.2025.106233_bib0030","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1158\/0008-5472.CAN-11-1218","article-title":"Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes","volume":"71","author":"Lovejoy","year":"2011","journal-title":"Cancer Res"},{"issue":"40","key":"10.1016\/j.htct.2025.106233_bib0031","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Whitnall","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.htct.2025.106233_bib0032","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/bjc.2012.582","article-title":"Dp44mT targets the AKT, TGF-beta and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells","volume":"108","author":"Dixon","year":"2013","journal-title":"Br J Cancer"},{"issue":"D1","key":"10.1016\/j.htct.2025.106233_bib0033","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925024976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925024976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:38:34Z","timestamp":1774701514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137925024976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2531137925024976"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2025.106233","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insights into the antiproliferative effect of the redox-active iron chelator Dp44mT on multiple myeloma cell lines","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2025.106233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106233"}}